NCT06821516 Comparison of Pain Relief Methods for Hip Surgery: A Study on Two Different Nerve Block Techniques
| NCT ID | NCT06821516 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Başakşehir Çam & Sakura City Hospital |
| Condition | Opioid Consumption, Postoperative |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2025-01-21 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2025-01-21 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized comparative study aims to compare the analgesic efficacy of pericapsular nerve group block (PENG) and lumbar erector spinae plane block (L-ESP) groups to relieve postoperative pain in participants over the age of 18 undergoing total hip arthroplasty under spinal anesthesia. The main question it aims to answer is: To demonstrate whether PENG block or L-ESP block is more effective in postoperative analgesia in patients undergoing total hip arthroplasty surgery based on pain scores, opioid consumption, and patient satisfaction. Total hip arthroplasties cause severe pain with movement in the postoperative period. After surgery, the movements of the participants are severely restricted, which increases the possibility of complications. In this study, the participants' pain status, VAS score, opioid consumption through patient-controlled analgesia, and patient satisfaction will be measured with a questionnaire for 24 hours at predetermined time points and then compared. Both types of blocks have pain-relieving effects. This study will only investigate which one is more effective in reducing pain, and there will be no deficiency in relieving the pain of the participants.
Eligibility Criteria
Inclusion Criteria: * Voluntary willingness to participate in the study. * Patients who will undergo Total Hip Arthroplasty surgery. * Patients aged over 18 years. * ASA score I-II-III. * Patients who are fully oriented and can cooperate. Exclusion Criteria: * ASA score IV-V. * Patients who refuse to participate in the study. * Patients under 18 years of age. * Presence of active infection in the area to be operated on. * Chronic pain and continuous analgesic use. * Patients with coagulation disorders. * Patients who cannot cooperate with postoperative pain follow-up. * Patients with allergies to local anesthetic agents. * Presence of neuropathy or myopathy in the operated extremity.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06821516 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Consumption, Postoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06821516 currently recruiting?
Yes, NCT06821516 is actively recruiting participants. Contact the research team at aberkaysune@gmail.com for enrollment information.
Where is the NCT06821516 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06821516 clinical trial?
NCT06821516 is sponsored by Başakşehir Çam & Sakura City Hospital. The trial plans to enroll 52 participants.